Lanean...
The shifting landscape of K(ATP) channelopathies and the need for ‘sharper’ therapeutics
ATP-sensitive potassium (K(ATP)) channels play fundamental roles in the regulation of endocrine, neural and cardiovascular function. Small-molecule inhibitors (e.g., sulfonylurea drugs) or activators (e.g., diazoxide) acting on SUR1 or SUR2 have been used clinically for decades to manage the inappro...
Gorde:
| Argitaratua izan da: | Future Med Chem |
|---|---|
| Egile Nagusiak: | , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Future Science Ltd
2016
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4976861/ https://ncbi.nlm.nih.gov/pubmed/27161588 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4155/fmc-2016-0005 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|